【摘 要】
：
Epigenetics is the main mechanism that controls transcription of specific genes with no changes in the underlying DNA sequences.Epigenetic alterations lead to abnormal gene expression patterns that contribute to carcinogenesis and persist throughout disea
【机 构】
：
Department of Molecular Medicine, University of Texas Health Science Center, San Antonio, TX 78229,
论文部分内容阅读
Epigenetics is the main mechanism that controls transcription of specific genes with no changes in the underlying DNA sequences.Epigenetic alterations lead to abnormal gene expression patterns that contribute to carcinogenesis and persist throughout disease progression.Because of the reversible nature,epigenetic modifications emerge as promising anticancer drug targets.Several compounds have been developed to reverse the aberrant activities of enzymes involved in epigenetic regulation,and some of them show encouraging results in both preclinical and clinical studies.In this article,we comprehensively review the up-to-date roles of epigenetics in the development and progression of prostate cancer.We especially focus on three epigenetic mechanisms:DNA methylation,histone modifications,and noncoding RNAs.We elaborate on current models/theories that explain the necessity of these epigenetic programs in driving the malignant phenotypes of prostate cancer cells.In particular,we elucidate how certain epigenetic regulators crosstalk with critical biological pathways,such as androgen receptor (AR) signaling,and how the cooperation dynamically controls cancer-oriented transcriptional profiles.Restoration of a “normal” epigenetic landscape holds promise as a cure for prostate cancer,so we concluded by highlighting particular epigenetic modifications as diagnostic and prognostic biomarkers or new therapeutic targets for treatment of the disease.
其他文献
Signaling through the vitamin D receptor has been shown to be biologically active and important in a number of preclinical studies in prostate and other cancers.Epidemiologic data also indicate that vitamin D signaling may be important in the cause and pr
Traditional approach to the prostate during radical prostatectomy (RP)when performed by open,laparoscopic,or robotic means has been from its anterior aspect first and has involved suture ligation and division of the dorsal vein complex (DVC),division of t
The prostate is an accessory sex gland that develops under precise androgenic control. It is known that hormonal imbalance may disrupt its development predisposing this gland to develop diseases during aging. Although the hypothesis regarding earlier orig
The aim of the present study was to determine whether oncologic outcomes and adverse events associated with active on/off intermittent antiandrogen monotherapy (daily bicalutamide,50 mg per day) are comparable with those of standard external beam radiatio
Prostate cancer (PCa) is the most common cause of malignancy in males and the third leading cause of cancer mortality in the United States.The standard care for primary PCa with local invasive disease mainly is surgery and radiation.For patients with dist
Despite great progress in the detection and treatment of prostate cancer,this disease remains an incredible health and economic burden.Although androgen receptor (AR) signaling plays a key role in the development and progression of prostate cancer,aberrat
Prostate cancer is a complex,heterogeneous disease that mainly affects the older male population with a high-mortality rate.The mechanisms underlying prostate cancer progression are still incompletely understood.Beta-adrenergic signaling has been shown to
Therapy resistance is a significant challenge for prostate cancer treatment in clinic.Although targeted therapies such as androgen deprivation and androgen receptor (AR) inhibition are effective initially,tumor cells eventually evade these strategies thro